Related Experiment Video
Updated: Jan 4, 2026

11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
23.0K
Reduced central sympathetic activity in Parkinson's disease
Heidrun H Krämer1, Gothje Lautenschläger1, Michael de Azevedo1
1Department of Neurology, Justus-Liebig-University, Giessen, Germany.
Brain and Behavior
|November 7, 2019
Summary
Sympathetic nervous system impairment in Parkinson's disease (PD) appears to stem from central dysfunction, not peripheral nerve issues. Reduced muscle sympathetic nerve activity (MSNA) in PD patients supports this central origin.
Area of Science:
- Neurology
- Autonomic Neuroscience
Background:
- Parkinson's disease (PD) is characterized by motor symptoms and often involves autonomic dysfunction.
- The precise origin of sympathetic nervous system impairment in PD, whether central or peripheral, remains unclear.
Purpose of the Study:
- To investigate whether sympathetic dysfunction in Parkinson's disease results from central or peripheral efferent nervous system issues.
- To differentiate between central and peripheral contributions to autonomic dysfunction in PD patients.
Main Methods:
- Compared 35 early-to-intermediate Parkinson's disease patients with 20 healthy controls.
- Assessed autonomic function via cardiovascular parameters, postprandial hypotension, orthostatic hypotension, and vasoconstriction responses to norepinephrine and cold.
- Measured muscle sympathetic nerve activity (MSNA) using microneurography and examined skin nerve biopsies for phosphorylated alpha-synuclein.
Main Results:
- Parkinson's disease patients exhibited higher diastolic blood pressure at rest and during orthostatic hypotension.
- Vasoconstriction responses to norepinephrine and cold were comparable between PD patients and controls.
- Muscle sympathetic nerve activity (MSNA) was significantly lower in PD patients, and phosphorylated alpha-synuclein was detected in their skin nerve biopsies.
Conclusions:
- Findings suggest no peripheral sympathetic nerve fiber dysfunction or altered adrenoreceptor sensitivity in Parkinson's disease.
- The observed reduction in muscle sympathetic nerve activity (MSNA) indicates a central sympathetic impairment in Parkinson's disease.
Related Concept Videos
Parkinson's Disease: Treatment
909
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
909
Parkinson's Disease: Overview
1.6K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.6K
Neural Regulation
43.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.0K
Disorders of the Autonomic Nervous System
1.4K
The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's...
Raynaud's disease, also known as Raynaud's...
1.4K
Brainstem
5.4K
The brainstem, located inferior to the brain and superior to the spinal cord, serves as a bridge between the cerebrum and the spinal cord. It plays a vital role in relaying information and controlling critical life functions. It comprises three primary regions: the midbrain, pons, and medulla oblongata.
The Midbrain
The midbrain is located beneath the diencephalon and connects the cerebrum with the lower parts of the brain. The cerebral peduncles are prominent midbrain structures that house the...
The Midbrain
The midbrain is located beneath the diencephalon and connects the cerebrum with the lower parts of the brain. The cerebral peduncles are prominent midbrain structures that house the...
5.4K
Drugs Affecting Neurotransmitter Synthesis
2.1K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.1K
